Bicycle Therapeutics plc (FRA:50BA)
Germany · Delayed Price · Currency is EUR 3.540
-0.240 (-6.35%)
Last updated: Jun 3, 2026, 9:55 AM CET
Bicycle Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 63.5 | 72.59 | 35.28 | 26.98 | 14.46 | 11.7 | |
Revenue Growth (YoY) | 146.85% | 105.77% | 30.76% | 86.52% | 23.65% | 12.58% |
Gross Profit | 63.5 | 72.59 | 35.28 | 26.98 | 14.46 | 11.7 |
Selling, General & Admin | 75.71 | 79.37 | 72.18 | 60.43 | 49.51 | 32.44 |
Research & Development | 230.13 | 240.28 | 172.97 | 156.5 | 81.61 | 44.88 |
Operating Income | -242.34 | -247.07 | -209.87 | -189.95 | -116.65 | -65.62 |
Interest Income | - | - | - | - | - | 0.12 |
Interest Expense | -0.2 | -0.21 | -1.73 | -3.26 | -3.34 | -2.98 |
Other Non-Operating Income (Expense) | 49.65 | 56.72 | 70.36 | 24.74 | 8.17 | -2.86 |
Total Non-Operating Income (Expense) | 49.45 | 56.51 | 68.63 | 21.48 | 4.82 | -5.73 |
Pretax Income | -217.62 | -218.81 | -173.8 | -179.21 | -114.24 | -68.48 |
Provision for Income Taxes | 1.41 | 0.15 | -4.77 | 1.46 | -1.52 | -1.66 |
Net Income | -219.03 | -218.96 | -169.03 | -180.66 | -112.72 | -66.82 |
Net Income to Common | -219.03 | -218.96 | -169.03 | -180.66 | -112.72 | -66.82 |
Shares Outstanding (Basic) | 69 | 69 | 58 | 36 | 30 | 25 |
Shares Outstanding (Diluted) | 69 | 69 | 58 | 36 | 30 | 25 |
Shares Change (YoY) | 7.09% | 19.02% | 63.54% | 20.00% | 18.35% | 30.90% |
EPS (Basic) | -3.15 | -3.16 | -2.90 | -5.08 | -3.80 | -2.67 |
EPS (Diluted) | -3.15 | -3.16 | -2.90 | -5.08 | -3.80 | -2.67 |
Shares Outstanding | 69.71 | 69.37 | 69.06 | 42.43 | 29.87 | 29.58 |
Free Cash Flow | -231.69 | -252.03 | -165.96 | -63.56 | -105.1 | -16.82 |
Free Cash Flow Per Share | -3.34 | -3.64 | -2.85 | -1.79 | -3.54 | -0.67 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -381.67% | -340.38% | -594.96% | -704.13% | -806.56% | -560.98% |
Profit Margin | -344.95% | -301.66% | -479.18% | -669.72% | -779.35% | -571.25% |
FCF Margin | -364.89% | -347.21% | -470.47% | -235.61% | -726.67% | -143.83% |
EBITDA | -236.43 | -240.64 | -202.7 | -183.4 | -112.96 | -64.21 |
EBITDA Margin | -372.35% | -331.53% | -574.62% | -679.86% | -781.06% | -548.94% |
EBIT | -242.34 | -247.07 | -209.87 | -189.95 | -116.65 | -65.62 |
EBIT Margin | -381.67% | -340.38% | -594.96% | -704.13% | -806.56% | -560.98% |
Effective Tax Rate | -0.65% | -0.07% | 2.74% | -0.81% | 1.33% | 2.43% |